Skip to content

Author

L. Ellisen

We have 3 of 43 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Antibody-drug conjugates in breast cancer: redefining targeted therapy

The biological basis and translational challenges of de novo and acquired resistance related to targets, payloads, and tumor microenvironmental constraints, as well as the implications of these mechanisms for biomarker development, sequencing rationales, and combination strategies with immune checkpoint inhibitors and...

Chen-Xu Guo, L. Ellisen · 0 citations
Open access Sep 2026

Actionable genetic landscape and dynamics in circulating DNA from 12,827 patients with metastatic breast cancer

This large collection of MBC cfDNA data is envisioned as an invaluable resource for the design and planning of future clinical trials, and cfDNA testing is now recommended in multiple advanced malignancies, including eligibility assessment for clinical trials.

I. Leshchiner, A. Medford, J. Cha et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.